Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Generic Clindamycin/Benzoyl Peroxide Gel vs Onexton in Acne Vulgaris
NCT02616614Phase 3Completed
- Sponsor
- Allergan
- Start
- May 2015
- Primary completion
- Oct 2015
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clindamycin + benzoyl peroxide in acne vulgaris, sponsored by Allergan. Started May 2015; status: completed.
02
Drugs
clindamycin + benzoyl peroxide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02616614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02616614.